Veeva Systems Inc.
General ticker "VEEV" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $41.7B (TTM average)
Veeva Systems Inc. follows the US Stock Market performance with the rate: 1.8%.
Estimated limits based on current volatility of 3.4%: low 160.58$, high 171.81$
Factors to consider:
- Total employees count: 7172 (+6.3%) as of 2024
- North America accounted for 58.7% of revenue in the fiscal year ended 2024-01-31
- Top business risk factors: Cybersecurity threats, Market competition, Customer concentration, Economic downturns and volatility, Migration challenges
- Current price 18.3% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-01-31 to 2027-01-31
- 2025-01-31 to 2026-01-31 estimated range: [198.87$, 276.02$]
- 2026-01-31 to 2027-01-31 estimated range: [205.46$, 285.19$]
Financial Metrics affecting the VEEV estimates:
- Negative: with PPE of 34.4 at the end of fiscal year the price was high
- Positive: Operating profit margin, % of 25.17 > 18.52
- Positive: 0.07 < Operating cash flow per share per price, % of 2.96
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Shareholder equity ratio, % of 79.46 > 64.25
- Positive: Return on assets ratio (scaled to [-100,100]) of 8.87 > 6.12
- Positive: Inventory ratio change, % of -0.93 <= -0.75
- Negative: Investing cash flow per share per price, % of -1.90 <= -0.65
Short-term VEEV quotes
Long-term VEEV plot with estimates
Financial data
| YTD | 2024-01-31 | 2025-01-31 | 2026-01-31 |
|---|---|---|---|
| Operating Revenue | $2,363.67MM | $2,746.62MM | $3,195.31MM |
| Operating Expenses | $1,934.34MM | $2,055.18MM | $2,278.94MM |
| Operating Income | $429.33MM | $691.43MM | $916.37MM |
| Non-Operating Income | $158.69MM | $227.95MM | $278.14MM |
| R&D Expense | $629.03MM | $693.08MM | $767.39MM |
| Income(Loss) | $588.02MM | $919.38MM | $1,194.51MM |
| Taxes | $62.32MM | $205.24MM | $285.60MM |
| Profit(Loss)* | $525.71MM | $714.14MM | $908.91MM |
| Stockholders Equity | $4,644.82MM | $5,832.37MM | $7,214.75MM |
| Assets | $5,910.92MM | $7,339.76MM | $8,979.34MM |
| Operating Cash Flow | $911.34MM | $1,090.05MM | $1,415.22MM |
| Capital expenditure | $26.20MM | $20.52MM | $29.13MM |
| Investing Cash Flow | $-1,076.35MM | $-700.14MM | $-1,104.36MM |
| Financing Cash Flow | $-16.19MM | $26.11MM | $-9.33MM |
| Earnings Per Share** | $3.27 | $4.41 | $5.55 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.